A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Clinical trial NCT07218029 · RECRUITING

Trial details

NCT number: NCT07218029
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2021-05-12
Primary completion: 2028-12-07
Enrollment: 815

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.